08092
| Double blind randomized phase III study of maintenance Pazopanib versus placebo in NSCLC patients non progressive after first line chemotherapy. |
22055C
| Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement |
08061
| Phase II study of sunitinib (SU11248) in patients with small cell lung cancer who are either chemo-naïve (extensive disease) or have a "sensitive" relapse. |
08072
| Concurrent once-daily versus twice-daily radiotherapy : A 2-arm randomised controlled trial of concurrent chemo-radiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (SCLC) and good performance status (CONVERT). |
08052
| Phase II study of bortezomib with cisplatin as first line treatment of malignant mesothelioma |
08062
| Randomization phase II study of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients with extensive stage SCLC (ES). |
08051
| Randomized Phase II Study Of Pemetrexed And Cisplatin As Either Induction or Adjuvant Chemotherapy In Stage IB-II Non-Small Cell Lung Cancer (NSCLC) |
08031
| Phase II feasibility trial of induction chemotherapy followed by extrapleural pneumonectomy and postoperative radiotherapy in patients with malignant pleural mesothelioma |
08013
| Phase II study with Gefitinib (sequentially) following Gemcitabine/Cisplatin as induction regimen for patients with stage IIIA N2 NSCLC |
08021
| A randomized phase III study of follow up with or without adjuvant Gefitinib (Iressa TM) following chemotherapy in patients with advanced Non-Small Cell Lung Cancer. |
08012
| Pre-operative chemotherapy in resectable NSCLC. Randomised trial of surgical resection with or without pre-operative chemotherapy in patients with operable non small cell lung cancer (NSCLC) of any stage. |
22003
| A multicenter randomised trial of high versus standard doses of prophylactic cranial irradiation in limited small cell lung cancer complete responders.
(An intergroup study with the PCI99-EULINT Collaborative Group, the EORTC Radiotherapy Group and the EORTC Lung Cancer Group.) |
08981
| Surgical treatment of stage IIIB non-small cell lung cancer after induction chemo-radiotherapy.
|
22993
| EORTC Study 22993-08993
Prophylactic cranial irradiation in extensive disease small cell lung cancer.
(A joint study with the EORTC Radiotherapy and Lung Cancer Groups) |
08984
| Taxotere and Cisplatin as induction chemotherapy in patients with
stage IIIa N2 non small cell lung cancer (NSCLC) |
16994N
| Open label phase II study on Glufosfamide administered as a 60 minute infusion every 3
weeks in advanced non small cell lung cancer: EORTC study 16994N |
08983
| Phase III study of Tomudex and Cisplatin versus Cisplatin
in Malignant Pleural Mesothelioma.
|
08992
| Phase II study on Tomudex in malignant mesothelioma.
|
08971b
| Survival in an international phase III prospective randomized LD small cell lung
cancer vaccination study with adjuvant BEC2 and BCG |
08972
| Randomized phase III study comparing induction chemotherapy to daily low dose cisplatin both combined with high dose radiotherapy in patients with inoperable non-small cell lung cancer stage I, II and (low volume) stage III. |
08975
| Randomised study with new combination chemotherapies in
advanced non-small cell lung cancer.
|
08976
| Phase II study: Temozolomide in malignant mesothelioma |
08971
| Survival in an international phase III prospective randomized LD small cell lung
cancer vaccination study with adjuvant BEC2 and BCG |
08965
| Temozolomide in advanced non-small cell lung cancer with and without brain
metastases: Phase II |
08966
| Phase II study on Caelyx in malignant mesothelioma. |
08962
| A phase III study of Marimastat in patients with small cell lung cancer following a response to first line chemotherapy. |
08956
| Phase II study on Taxol in bronchioalveolar carcinoma |
08958
| Phase II study on Carboplatin and Taxol as induction regimen in stage IIIa (N2) non-small cell lung cancer (NSCLC) |
08957
| Phase II study on Topotecan in combination with Cisplatin as second line treatment of small cell lung cancer |
08961
| Phase II study of VIP (Etoposide, Ifosfamide and Cisplatin) in the treatment of invasive thymoma (In collaboration with ECOG, SWOG and CALGB) |
08951
| Phase III trial on sequential radiotherapy with or without daily Cisplatin in patients with small cell lung cancer limited to chest and good response to induction chemotherapy |
08955
| A phase II study of Gemcitabine and Cisplatin as induction regimen in stage IIIa non-small cell lung cancer. |
08943
| Gemcitabine in malignant mesothelioma : a phase II study |
08952
| Adjuvant chemotherapy in completely resected stage I, II, and IIIa non-small cell lung cancer. A prospective randomized Phase III inter-group study (In collaboration with the Adjuvant Lung Project Italy - ALPI) |
08941
| Randomized trial of surgery versus radiotherapy in patients with stage IIIa
non-small cell lung cancer after a response to induction-chemotherapy. |
08923
| A phase III study of standard CDE vs intensified CDE with G-CSF + prophylactic antibiotics in small cell lung cancer |
08925
| A randomized trial of two Cisplatin-based combination chemotherapies in advanced non-small cell lung cancer. A phase II study leading to a phase III |
08924
| A phase II study of Taxol in mesothelioma |
08921
| UK02 EORTC/MRC/UKCCCR collaborative randomized phase III study of prophylactic cranial irradiation in patients with small cell lung cancer of limited extent who achieve a complete response to induction chemotherapy |
08911
| Phase II trial of oral ifosfamide vs intravenous ifosfamide in advanced non small cell lung cancer |
08902
| Phase II trial of suramin in advanced non small cell lung cancer |
08891
| The role of radiotherapy in the treatment of brain metastases of small cell lung cancer. A phase II and phase III study |
08901
| Etoposide in mesothelioma. A phase II study of cotinuous chemotherapy |
08892
| Phase II trial of Navelbine (Vinorelbine) in pretreated patients with small cell carcinoma of the lung |
08883
| Phase III trial on the evaluation of gamma Interferon for intensification/ maintenance of complete or near complete response in small cell lung cancer |
08881
| A RANDOMIZED MULTI-CENTRE STUDY TO COMPARE THE EFFICACY AND TOLERABILITY OF ICS 205-930 WITH A METOCLOPRAMIDE-CONTAINING ANTIEMETIC COCKTAIL FOR THE PREVENTION OF CISPLATIN-INDUCED EMESIS. |
08882
| Phase III trial of standard versus alternating chemotherapy in small cell lung cancer, extensive disease |
08877
| Alternating versus sequential radio-chemotherapy in limited disease small cell lung cancer; a randomized phase III study |
08878
| Phase II study of etoposide in malignant mesothelioma |
08871
| EUROSCAN: Phase III randomized study of chemoprevention with vitamin A and N-acetylcysteine in patients curatively treated for carcinomas of the larynx, oral cavity and lung (Jointly with the EORTC Head and Neck Cooperative Group : Protocol 24871) |
08875
| Phase III randomized trial in metastatic non-small cell lung cancer |
08873
| E.O.R.T.C. BRONCHIAL COOPERATIVE GROUP TENIPOSIDE FOR BRAIN METASTASES OF SMALL CELL LUNG CANCER. |
08872
| PHASE II TRIAL OF ACNU WITH ADVANCED SMALL AND NON-SMALL CELL CARCINOMA OF THE LUNG. |
08863
| CHEMOTHERAPY FOLLOWED BY SURGERY AND RADIOTHERAPY IN NSCLC PATIENTS WITH BIOPSY PROVEN N2 DISEASE. A PHASE II STUDY. |
08864
| Phase II Chemotherapy with 4'-Epidoxorubicin in Patients with Mesothelioma |
08862
| STANDARD COMBINATION CHEMOTHERAPY IN SMALL CELL LUNG CANCER, A PHASE II TRIAL. |
08855
| Phase II Chemotherapy with Mitozolomide in Advanced Small and non-Small Cell Carcinoma of the Lung |
08854
| PHASE II TRIAL OF 4'-EPIDoxorubicin IN ELDERLY OR UNFIT UNTREATED PATIENTS WITH ADVANCED SMALL CELL CARCINOMA OF THE LUNG. |
08853
| Phase II trial of cisplatin-etoposide combination in recurrent or metastatic invasive thymoma |
08845
| ADJUVANT SURGERY AFTER INDUCTION CHEMOTHERAPY IN LIMITED SMALL CELL LUNG CANCER A RANDOMIZED PROSPECTIVE STUDY. |
08852
| Mitoxantrone in Mesothelioma : a phase II study |
08841
| Phase II Chemotherapy with High-Dose VP-16213 for Brain Metastases in Patients with Small Cell Lung Cancer |
08844
| Randomized phase III trial comparing radiotherapy + weekly cisplatin vs radiotherapy + daily cisplatin for inoperable non-small cell bronchogenic carcinoma (jointly with the EORTC Radiotherapy Cooperative Group) |
08842
| COMBINATION CHEMOTHERAPY + SPLIT-DOSE RADIOTHERAPY, A RANDOMIZED PHASE II STUDY |
08843
| Randomized Comparison of Adjuvant Postoperative Combination Chemotherapy with CED (CTX/VP-16/ADR) vs Resection Alone in Patients with Stage I Small Cell Carcinoma of the Lung |
08825
| Induction vs induction plus maintenance chemotherapy in SCLC, a phase III trial |
08792
| Phase II trial of pepleomycin in advanced recurrent or metastatic non-small cell carcinoma of the lung |
08812
| Phase II trial with ametantrone in patients with advanced bronchogenic carcinoma |
08822
| Phase II trial of ellipticinium acetate in patients with advanced bronchogenic carcinoma |
08743
| Comparison of radiotherapy and chemotherapy in anaplastic bronchial cancer |
08824
| Phase III trial of immediate versus delayed radiotherapy in non-operable "non-symptomatic" non-small cell lung cancer |
08761
| Essai sur l'efficacité d'un traitement avec vincristine, adriamycine et mechloretamine dans les cancers epidermoïdes bronchiques opérés (protocole 08741) sortis de l'étude pour apparition de récidive ou de métastases |
08763
| Immunochimiothérapie (coryne bacterium parvum - CCNU + ADM) de l'epithelioma broncho-pulmonaire non opérable et non irradiable - phase III |
08762
| Essai sur l'efficacité d'un traitement avec vincristine, adriamycine et mechloretamine dans les cancers epidermoides bronchiques localisés, irradiés, n'entrant pas dans le protocole 08742 pour manque d'efficacité de la radiothérapie, ou sortant de ce protocole pour récidive ou métastases |
08762
| Essai sur l'efficacité d'un traitement avec vincristine, adriamycine et mechloretamine dans les cancers epidermoïdes bronchiques localisés, irradiés, n'entrant pas dans le protocole 08742 pour manque d'efficacité de la radiothérapie, ou sortant de ce protocole pour récidive ou métastases |
08764
| Comparaison d'une immunochimiothérapie myelotoxique mensuelle (A) et d'une association d'une immunochimiothérapie myelotoxique et non myelotoxique (A + B) dans les cancers bronchiques à petites cellules |
08741
| Comparison of the effects of no treatment, chemotherapy, immunotherapy, and a combination chemotherapy-immunotherapy in post-operative epidermoid bronchial cancer, irradiated or not |
08742
| Effect of a chemotherapy, immunotherapy (not specific), combination immunotherapy-chemotherapy in localized primary epidermoid bronchial cancer postradiotherapy |
08742
| Effect of a chemotherapy, immunotherapy (not specific), combination immunotherapy-chemotherapy in localized primary epidermoid bronchial cancer postradiotherapy |
22055
| Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement - LUNG-ART |
